Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine

Efficacy and Safety of Antimalarial as Repurposing Drug for COVID-19 Following Retraction of Chloroquine and Hydroxychloroquine

Irma Rahayu Latarissa,1,2 Miski Aghnia Khairinisa,1 Ghina Nadhifah Iftinan,2 Anna Meiliana,1,3 Ida Paulina Sormin,4,5 Melisa Intan Barliana,6,7 Keri Lestari1,2,7 1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia; 2Medication Therapy...

Full description

Saved in:
Bibliographic Details
Main Authors: Latarissa IR, Khairinisa MA, Iftinan GN, Meiliana A, Sormin IP, Barliana MI, Lestari K
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:Clinical Pharmacology: Advances and Applications
Subjects:
randomized controlled trial
quinine sulfate
atovaquone
artemisin-piperaquine
sars-cov-2.
Online Access:https://www.dovepress.com/efficacy-and-safety-of-antimalarial-as-repurposing-drug-for-covid-19-f-peer-reviewed-fulltext-article-CPAA
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/efficacy-and-safety-of-antimalarial-as-repurposing-drug-for-covid-19-f-peer-reviewed-fulltext-article-CPAA

Similar Items